Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2026 Aug 18;70(16):e70591. doi: 10.1002/mnfr.70591

The Hidden Burden of Water‐Binding Additives in Meat Products: Biochemical, Clinical, and Psychosocial Implications

Oleksandr Kamyshnyi 1,2, Iryna Halabitska 3, Magnar Bjorås 4,5,6, Ingrid Bjørnes Sæther 4, Trygve Brautaset 4, Iryna Kamyshna 7, Oleh Lushchak 2, Valentyn Oksenych 4, Pavlo Petakh 2,8,✉, Denis E Kainov 4,✉
PMCID: PMC13487355  PMID: 42613892

ABSTRACT

Processed meat products are widely consumed worldwide, especially because they are affordable and easy to prepare. Their production often involves the use of water‐binding additives such as phosphates, nitrites, and sodium chloride. Although these substances improve taste, texture, and shelf life, their potential effects on human health remain unclear. This review aims to summarize current knowledge about the possible biological and clinical effects of these additives. Injection (brining) technology is commonly used to increase product weight and improve quality. However, it may also lead to regular consumption of these additives. Phosphates may influence mineral balance and could be linked to changes in vitamin D metabolism and vascular health. Nitrites can participate in the formation of N‐nitroso compounds, which have been shown to have harmful effects in experimental studies. High sodium intake is associated with increased blood pressure and cardiovascular risk. Some studies also suggest that these additives may affect the gut microbiota and promote low‐grade inflammation. Certain groups, including people with chronic diseases, may be more sensitive to these effects. Cultivated meat has been proposed as a potential alternative that may reduce reliance on such additives; however, it often still requires similar ingredients to achieve desired texture and stability, and its potential health benefits remain uncertain. Current regulations in the United States and the European Union primarily focus on individual additives and do not fully account for total daily intake from different foods. In addition, food labels often do not provide detailed quantitative information. Further research is needed to better understand long‐term effects and combined exposure.

Keywords: carcinogenesis, food safety, food additives, metabolic syndrome, processed meat


Graphical abstract illustrating how brining technology introduces water‐binding additives into processed meat. Their cumulative exposure may promote oxidative stress, inflammation, dysbiosis, and endothelial dysfunction, contributing to cardiovascular disease, chronic kidney disease, colorectal cancer, and metabolic burden, while highlighting the need for improved labeling and safer formulations.

graphic file with name MNFR-70-e70591-g002.jpg

1. Food Additives in Processed Meat Products: Prevalence, Technological Applications and Health RSisks

Processed meat products are among the most widely consumed foods in the world, especially in cities and among lower‐income populations, where their relative accessibility and ease of preparation determine a sustainable demand [1, 2]. The meat processing industry actively uses moisture‐retaining food additives, in particular, phosphates, nitrites, and injectable salt solutions, which significantly improve the organoleptic properties and technological characteristics of the finished product [3, 4]. These substances increase the product's weight by approximately 15%–30%, enhance juiciness, and extend shelf life. At the same time, their use can reduce the food and nutritional value of the product by diluting the protein content and changing the structure of the tissues [5, 6, 7]. Despite its prevalence, this practice remains little known to the general consumer due to insufficient labeling and gaps in regulatory requirements [8].

Concerns about the effects of consuming such products gained clear scientific support in 2015, when the International Agency for Research on Cancer (IARC) of the World Health Organization classified processed meat as a Group 1 carcinogen, i.e., a substance with a proven link to the development of malignant neoplasms in humans. In particular, a statistically significant association was found between regular consumption of such products and an increased risk of colorectal cancer (CRC) [9]. In parallel, the European Food Safety Authority (EFSA) emphasized that dietary phosphate intake among the EU population often exceeds safe levels, particularly for vulnerable groups such as children, the elderly, and people with chronic kidney disease [10, 11, 12]. From a biochemical perspective, individual classes of food additives exert their negative effects through distinct molecular mechanisms [13, 14]. Excess dietary phosphate intake has been associated with disruptions in mineral homeostasis, including alterations in parathyroid hormone and fibroblast growth factor 23 (FGF‐23), and has been linked to vascular calcification and increased cardiovascular risk [15]. Nitrites, in turn, react with secondary and tertiary amines in the acidic environment of the stomach or during endogenous metabolism to form N‐nitroso compounds, a class of substances with established mutagenic and carcinogenic potential that can induce DNA alkylation in colonic mucosal cells [16, 17]. Finally, high sodium concentrations in processed meat products are associated with activation of the renin–angiotensin–aldosterone system, leading to increased blood pressure and fluid retention and placing a greater burden on the cardiovascular and renal systems [18, 19, 20].

Epidemiological evidence supports and extends these mechanistic observations. Large prospective cohort studies have consistently reported associations between regular consumption of processed meat and increased risk of obesity, cardiovascular disease, chronic kidney disease, and colorectal cancer; however, causal relationships remain uncertain [16, 21, 22, 23]. However, certain population, particularly those with pre‐existing renal dysfunction, metabolic syndrome, or genetic predisposition to dysregulation of calcium and phosphorus metabolism—are more susceptible to these effects, suggesting the need for differentiated health care approaches [21, 24, 25, 26]. Taken together, these data suggest that the impact of food additives in processed meat on human health is not only a toxicological but also a systemic health and social problem [27, 28]. Deepening knowledge about the molecular mechanisms of their action is a prerequisite for scientifically substantiating regulatory policy, improving labeling standards, and formulating evidence‐based dietary recommendations, especially for vulnerable populations [21, 29].

Unlike previous reviews that primarily focus on individual additives or specific disease outcomes, this review integrates the cumulative and potentially synergistic effects of multiple food additives commonly present in processed meat. In particular, it emphasizes the concept of cumulative exposure and the combined biological impact of phosphates, sodium, and nitrites across multiple organ systems.

A key contribution of this review is the conceptualization of processed meat additives not as isolated risk factors, but as components of a cumulative exposure system that may exert synergistic biological effects across metabolic, cardiovascular, and oncological pathways.

2. Methods

This study is a narrative review with elements of a structured literature search. Its aim is to summarize current evidence on the biochemical, clinical, and possible psychosocial effects of water‐binding additives in processed meat products, such as phosphates, nitrites, and sodium chloride.

A literature search was carried out using the databases PubMed/MEDLINE, Scopus, and Web of Science. We included studies published between January 2000 and January 2026. The search used the following keywords: “processed meat”, “food additives”, “phosphates”, “nitrites”, “sodium intake”, “gut microbiota”, “cardiovascular disease”, “chronic kidney disease”, “colorectal cancer”, “ultraprocessed food”, and “cultivated meat”. These terms were combined using the operators AND and OR.

We included peer‐reviewed articles published in English. The selected studies included human epidemiological studies, experimental studies (both in vivo and in vitro), and systematic reviews and meta‐analyses. We focused on studies that examined the biological, clinical, or microbiome‐related effects of food additives. We excluded nonpeer‐reviewed sources, articles not related to processed meat or additives, and studies with unclear methods.

This review has some limitations. As a narrative review, it may be subject to selection bias. In addition, most human data are observational, making it difficult to establish cause‐and‐effect relationships. Differences between studies also limit direct comparison of results.

3. Biochemical and Microbiological effects

3.1. Injection (Brining) Technology

Injection is one of the most common meat processing technologies used to improve product quality and ensure its microbiological safety (Table 1). The method consists of injecting a solution containing water and functional additives, in particular, sodium chloride, phosphates, and nitrites, directly into muscle tissue using specialized injector needles (Figure 1) [5, 30]. Uniform distribution of brine throughout the product allows for a shorter processing cycle than traditional salting and ensures reproducibility of organoleptic characteristics in industrial production [31, 32]. Despite the obvious technological advantages, this process is biochemically complex and can have both positive and potentially negative effects on the nutritional value of the finished product [33, 34].

TABLE 1.

Composition of typical brines used in meat and poultry processing.

Component Function Typical Concentration (%)
Water [57], [58] Bulk filler, increases weight 5–20
Sodium chloride [59, 60] Flavor, osmotic balance, preservation 1–3
Phosphates [61, 62, 63] pH buffering, water retention 0.3–0.5
Nitrites (NaNO2) [50, 64] Color stabilization, antimicrobial 50–200 ppm
Citrates [65] Antioxidant, synergy with phosphates 0.1–0.3
Protein hydrolysates [66, 67] Improve texture, bind water 0.5–1

FIGURE 1.

FIGURE 1

Brine Injection in Meat Processing Illustration of hollow needles injecting brine (water, sodium chloride, phosphates, nitrites) into muscle fibers, increasing water retention and product weight while diluting nutritional value. This figure highlights the industrial process driving additive exposure.

Phosphates play a central role in the mechanism of injection action on meat tissue. Due to their alkalizing effect, they increase the pH of muscle tissue, altering the spatial configuration of myofibrillar proteins, actin, and myosin [35, 36, 37]. In particular, an increase in pH above the isoelectric point of myosin increases the electrostatic repulsion between protein molecules, which may contribute to loosening of the myofibrillar network and expansion of the space between muscle fibers [38, 39]. As a result, meat acquires the ability to retain a significantly larger volume of moisture—both before and after heat treatment—which ensures increased juiciness and tenderness of the finished product [40, 41]. At the same time, excessive addition of phosphates can disrupt the product's mineral balance and increase dietary phosphorus intake, posing a potential risk for people with impaired kidney function and a tendency toward vascular calcification [42]. Nitrites perform several interrelated key functions in the composition of brine. First, they stabilize the pink‐red color of meat through the formation of nitrosomyoglobin, a stable pigment resulting from the interaction of nitrite with myoglobin in muscle tissue [43, 44]. This characteristic plays a significant role in consumer perception of product quality, as it is traditionally associated with freshness and an attractive presentation [45]. Second, nitrites exhibit pronounced antimicrobial activity, inhibiting the growth of dangerous pathogenic microorganisms, primarily Clostridium botulinum, and slowing down the processes of microbial spoilage by inhibiting the enzymatic metabolism of the bacterial cell [46, 47]. However, nitrites can react with secondary amines present in meat proteins, forming N‐nitroso compounds — a chemical class of substances with proven mutagenic and carcinogenic potential [48, 49]. This process occurs both directly in the product during heat treatment (endogenous nitrosation) and in the consumer's gastrointestinal tract with the participation of nitrosating bacteria, which is especially relevant in the context of chronic consumption of such products [45, 46]. These circumstances emphasize the need for strict control of nitrite concentration in brine formulations and the search for safer functional alternatives. Importantly, the biological effects of nitrites are strongly influenced by other ingredients present in meat formulations. Ascorbic acid (vitamin C) and sodium erythorbate inhibit N‐nitrosamine formation by accelerating nitric oxide generation and reducing nitrosating intermediates, whereas citrate contributes antioxidant and metal‐chelating properties that may further suppress nitrosation reactions. Consequently, the potential health impact of nitrites depends not only on nitrite concentration but also on the overall formulation and processing conditions [44, 49, 50]. Thus, injection technology is an effective, technologically sound means of improving the quality and safety of meat products [44, 51]. At the same time, its implementation requires careful control of the dosage of functional ingredients and a deep understanding of their biochemical and microbiological action [52, 53]. In particular, it is necessary to take into account that the simultaneous presence of phosphates, nitrites, and sodium chloride in the brine composition may cause synergistic or antagonistic effects at the molecular level, which are currently insufficiently studied [54, 55, 56]. Further research should combine the analysis of molecular mechanisms of action of individual additives with a comprehensive assessment of their impact on long‐term human health, especially in vulnerable populations.

Recent technological advances aim to reduce additive requirements while maintaining product quality and microbiological safety. These include low‐temperature fermentation using protective starter cultures, antioxidant‐assisted curing systems, precision brining technologies, and natural antioxidant formulations, all of which have demonstrated potential to decrease nitrite and phosphate usage without compromising product quality [50, 51, 56, 66].

3.2. Biochemical Transformations

Inorganic phosphates, which enter the body as part of processed meat products, exhibit significantly higher bioavailability than organically bound phosphorus from plant sources: their intestinal absorption reaches 80%–100%, whereas for phytate phosphorus it does not exceed 40%–60% [34, 68]. Such efficient absorption may contribute to a rapid, pronounced increase in blood serum inorganic phosphate concentration, associating with a cascade of compensatory endocrine responses. In particular, hyperphosphatemia inhibits the activity of renal 1α‐hydroxylase, a key enzyme that catalyzes the conversion of 25‐hydroxycholecalciferol to calcitriol (1,25‐dihydroxycholecalciferol), the active form of vitamin D [68, 69]. Calcitriol deficiency, in turn, may reduce intestinal calcium absorption and enhance secondary hyperparathyroidism, and has been associated with adverse effects on bone mineral density and an increased risk of osteopenia [69, 70, 71].

In parallel, excess blood phosphate directly stimulates the proliferation and phenotypic transformation of vascular smooth muscle cells, which acquire osteoblast‐like properties and begin to synthesize an extracellular matrix prone to mineralization [72, 73, 74]. This process has been associated with increased arterial stiffness, impaired vascular elasticity, and elevated cardiovascular risk (Table 2) [72, 75].

TABLE 2.

Biochemical and microbial effects of water‐binding additives.

Additive Main target Mechanism of action Health effect
Phosphates [97, 98] Mineral metabolism ↑ Serum phosphate, ↓ calcitriol, ↑ ROS CKD, vascular calcification, aging
Nitrites [99, 100] DNA integrity, microbiota Nitrosamine formation, dysbiosis Potential association with CRC (observational evidence), possible gut barrier alterations
Sodium [101, 102, 103] Fluid balance, microbiota Water retention, microbiota shifts Hypertension, obesity, immune dysregulation
Injected water [104] Protein density Dilution of nutrient content Reduced dietary quality, malnutrition

At the cellular level, excess phosphate disrupts mitochondrial function by altering the permeability of the inner mitochondrial membrane and destabilizing the electron transport chain, leading to increased electron leakage and excessive production of reactive oxygen species (ROS) [76, 77, 78]. These unstable molecule, including superoxide anion, hydrogen peroxide, and hydroxyl radicals, can oxidize cell membrane lipids, proteins, and DNA molecules [79, 80, 81]. The accumulation of such damage may contribute to accelerated cellular aging and has been hypothesized to increase susceptibility to chronic diseases, including cancer (Table 2) [82, 83, 84]. Oxidative stress also activates proinflammatory signaling pathways, including NF‐κB, further exacerbating the low‐grade systemic inflammation associated with metabolic syndrome and atherosclerosis [85, 86, 87].

Nitrites in brines exert their adverse effects primarily by endogenously forming N‐nitroso compounds. Under acidic conditions in the stomach or with the participation of nitrosating bacteria in the colon, nitrites react with secondary and tertiary amines of meat proteins to form nitrosamines and nitrosamides [28]. Experimental in vitro studies and animal models have been shown in experimental systems to alkylate DNA in colonic mucosal cells, inducing mutations in tumor suppressor genes and potentially contributing to malignant transformation, consistent with the mechanistic basis for the association between processed meat consumption and an increased risk of colorectal cancer established by IARC [88, 89]. Excess sodium, an integral component of most brines, has an additional negative effect by impairing renal regulation of water‐salt balance [90, 91, 92]. Chronically elevated sodium intake inhibits the activity of Na+/K+‐ATPase in renal tubular cells, which increases sodium and water reabsorption and activates the sympathetic nervous system and the renin–angiotensin–aldosterone axis [93, 94]. The combined effect of these mechanisms is associated with sustained increases in blood pressure and cardiac preload, which may contribute over time to left ventricular hypertrophy and an increased risk of heart failure (Table 2) [95, 96].

3.3. Microbiota and Immune Dysregulation

Nitrites may indirectly influence gut and cardiovascular health; however, their role in TMAO metabolism remains incompletely understood [95, 105]. TMAO has been associated with inflammation and increases the risk of cardiovascular disease [106, 107, 108]. Phosphates also negatively affect the body, in particular the composition of the gut microbiota. Evidence from mouse and rat studies suggests that high‐phosphate diets promote the growth of pathogenic bacteria while reducing overall gut microbial diversity [109, 110, 111]. Reduced microbial diversity has been associated with impaired resilience of host defense mechanisms and altered immune balance, primarily in experimental animal studies [112, 113]. Excess sodium also affects the immune system. Both human intervention studies and experimental animal models have demonstrated activation of Th17 cells in response to high sodium intake [114, 115]. Excessive activation of these cells may contribute to tissue damage and the development of autoimmune disorders, as demonstrated mainly in experimental models [116, 117, 118, 119]. When these changes occur simultaneously, an imbalance in the gut microbiota results. The production of short‐chain fatty acids, such as butyrate, which normally support the strength and health of the intestinal mucosa, is reduced [120, 121, 122]. The lack of sufficient amounts of these acids weakens the intestinal barrier, making it more permeable to pathogens [123, 124, 125]. A weakened intestinal barrier may facilitate the translocation of microorganisms, which may be associated with increased susceptibility to infections [126, 127]. This may be associated with altered host defense mechanisms and potential changes in susceptibility to certain infections; however, direct clinical evidence remains limited [128, 129, 130, 131]. However, current evidence linking food additive exposure to microbiota‐mediated disease outcomes remains limited, and causal relationships have not been established in humans. Most available data are derived from experimental or animal studies, and their relevance to human health requires further investigation. Most evidence linking high sodium intake to gut microbiota alterations is derived from experimental animal studies, whereas direct evidence in humans remains limited. Nevertheless, excessive sodium intake is well established as an independent risk factor for hypertension, cardiovascular disease, and chronic kidney disease, providing a strong clinical rationale for limiting dietary sodium intake irrespective of its microbiota‐related effects.

4. Health and Psychosocial Impacts

4.1. Cancer Risk

The consumption of processed meat is one of the best‐documented dietary risk factors for colorectal cancer (CRC). Large human epidemiological studies and meta‐analyses suggest that this dietary pattern is responsible for approximately 10%–15% of CRC cases in developed countries [132, 133, 134]. The mechanistic basis for this association is the endogenous formation of N‐nitroso compounds in the acidic environment of the stomach and by nitrosating bacteria in the distal intestine [134]. Experimental animal and in vitro studies have shown that these compounds are associated with DNA alkylation in colonic mucosal cells, causing mutations in tumor suppressor genes, including APC, TP53, and MLH1, and thereby potentially contributing to malignant epithelial transformation [132, 135]. Regular and prolonged intake of nitrites, nitrates, and preservatives in processed meat creates a chronically unfavorable intestinal microenvironment that supports the proliferation of transformed cells and inhibits apoptosis [136, 137]. It remains challenging to distinguish the effects of specific additives from those of the processed meat matrix as a whole.

It is important to distinguish hazard identification from individual risk assessment. The IARC Group 1 classification reflects the strength of evidence that processed meat can cause cancer under conditions of sufficient exposure but does not imply that occasional consumption represents a high individual risk. Epidemiological studies indicate that elevated colorectal cancer risk is primarily associated with regular long‐term intake [22, 138].

4.2. Cardiovascular and Renal Consequences

Excessive phosphate intake is particularly dangerous for individuals with chronic kidney disease (CKD). Clinical studies in patients with CKD indicate that reduced renal phosphorus excretion contributes to persistent hyperphosphatemia, which has been associated with accelerated CKD progression by activating profibrotic signaling pathways, stimulating FGF‐23 synthesis, and creating a vicious cycle of mineral and bone disorders (Figure 2) [139, 140, 141]. In parallel, hyperphosphatemia enhances systemic inflammation by activating NF‐κB and increasing levels of proinflammatory cytokines‐particularly IL‐6 and TNF‐α. These findings have been reported in patients with CKD as well as supported by experimental studies, and further contribute to the progression of atherosclerosis and increased cardiovascular mortality in this patient group [139, 141, 142].

FIGURE 2.

FIGURE 2

Trends in Processed Meat Consumption and Health Outcomes A line chart illustrating global processed meat consumption (kg per capita, 1990–2025) alongside rising obesity and CRC rates in high‐income countries. Data sources: FAO, WHO, GLOBOCAN. This figure highlights the parallel increase in additive exposure and disease burden.

Excess dietary sodium and nitrites act synergistically in shaping cardiovascular risk. Chronically elevated sodium intake activates the renin–angiotensin–aldosterone system, increasing blood pressure and myocardial preload [88, 143]. Nitrites, in turn, have been shown in experimental animal and cellular studies to stimulate the production of proinflammatory eicosanoids and increase the expression of adhesion molecules on endothelial cells, facilitating the transmigration of monocytes into the vascular wall and accelerating the formation of atherosclerotic plaques [144, 145]. The combined effect of these mechanisms is associated with an increased risk of acute cardiovascular events—myocardial infarction and ischemic stroke—and also contributes to the development of endothelial dysfunction, which is an early and sensitive marker of vascular damage [88, 146, 147]. These associations may also reflect broader dietary patterns characterized by high intake of ultraprocessed foods.

4.3. Integrative Risk Assessment

The evidence presented demonstrates that excessive consumption of processed meat and its key components—phosphates, nitrites, and sodium—suggests a complex and potentially interconnected pathophysiological network that encompasses oncological, cardiovascular, metabolic, neuropsychiatric, and microbiome disruptions (Figure 3). It is important to emphasize that these effects are not independent: systemic inflammation, endothelial dysfunction, insulin resistance, and dysbiosis form mutually reinforcing feedback loops that significantly increase the overall burden of disease at the population level. The available evidence from human observational studies, supported by experimental animal and mechanistic investigations, supports consideration of limiting consumption of such products, particularly in high‐risk populations [128, 132, 139, 148, 149, 150].

FIGURE 3.

FIGURE 3

Pathways from Additives to Dysbiosis and Disease Flowchart depicting how water‐binding additives disrupt gut microbiota, leading to immune dysregulation, infection susceptibility, obesity (via inflammation, water retention), and depression (via gut–brain axis, HPA dysregulation).

Emerging evidence indicates that dietary interventions may attenuate some adverse biological effects associated with processed meat additives. Dietary fiber promotes short‐chain fatty acid production and supports intestinal barrier integrity, polyphenols reduce oxidative stress and inflammation, probiotics help restore gut microbial balance, whereas adequate vitamin D status may improve phosphate homeostasis. Although these interventions cannot eliminate additive exposure, they may reduce susceptibility to some downstream metabolic disturbances [151, 152, 153].

5. Cultivated Meat as a Potential Strategy to Reduce Additive‐Related Health Risks

Given growing concerns about the cumulative health effects of water‐binding additives in processed meat, there is increasing interest in alternative protein sources that may reduce reliance on such additives [154]. Cultivated meat has emerged as a promising approach that allows for controlled production conditions and the potential to minimize or optimize the use of functional additives [155, 156]. Therefore, examining the role of water‐binding additives in cultivated meat systems provides an important perspective on how future food technologies may address current health risks.

Cultivated meat is produced by growing cells in bioreactors as a more sustainable alternative to traditional meat [157]. It often has a lower water‐holding capacity (WHC) due to the immature tissue structure and high moisture content. This may lead to water loss during cooking, freezing, or reheating, thereby degrading dish quality. Water‐binding additives (WBA) help improve the juiciness, texture, and stability of the product [158].

The main WBAs include: Hydrocolloids (alginate, carrageenan, gellan gum, pectin, xanthan, and konjac‐glucomannan), Protein additives (transglutaminase (MTG), whey proteins, gelatin, and zein), and others (dietary fibers, modified starches, and crosslinking agents). They form gel structures, bind water, and mimic the natural extracellular matrix, stabilizing the product [159, 160].

Although hydrocolloids are frequently marketed as clean‐label alternatives, they cannot be regarded as biologically inert. Experimental studies suggest that carrageenan may impair intestinal barrier integrity and promote intestinal inflammation under certain conditions, whereas xanthan gum may cause gastrointestinal discomfort at high intake levels. Alginate is generally considered well tolerated, although it may influence gastric emptying and intestinal viscosity. Current human evidence remains limited, and further studies are required to clarify long‐term gastrointestinal effects [161, 162, 163].

WBAs increase water‐holding capacity and reduce cooking losses, maintaining juiciness. Alginate hydrogels improve structure, strength, and moisture retention. When combined with fats (alginate, MTG), they form a texture similar to natural meat, preventing delamination during heating. Hydrocolloids also contribute to the formation of a fibrous structure and increase tenderness. Dietary fibers and konjac glucomannan additionally retain water and improve product stability [164, 165, 166].

Excess hydrocolloids can make the texture too soft or gel‐like. The demand for a “clean label” limits the use of synthetic additives. In liquid dishes, stratification can occur if an excessive amount is added. The optimal concentration is usually 0.5%–3% (Figure 4) [167, 168, 169].

FIGURE 4.

FIGURE 4

Integration of water‐binding additives into the cultured meat production process. The diagram illustrates the complete technological chain of cultured meat production—from cell selection and proliferation to tissue formation and obtaining the final product. Special attention is paid to the role of water‐binding additives, which are incorporated at various stages to enhance structure, stability, and water‐holding capacity. The combination of bioengineering approaches, 3D printing, and functional ingredients ensures a product with properties similar to traditional meat.

Recent research is aimed at creating natural and functional scaffolds (e.g., alginate and protein‐based) and hybrid products. This allows for cultured meat with better texture and juiciness for different dishes and meets sustainable and consumer requirements [164, 170, 171].

However, it should be emphasized that cultivated meat does not inherently eliminate the need for water‐binding additives. In many cases, hydrocolloids and protein‐based binders are still required to achieve desirable texture and stability. Therefore, the potential health benefits of cultivated meat depend not only on the production system itself but also on the formulation and regulatory oversight of additive use. Further research is needed to evaluate whether these systems truly reduce cumulative additive exposure compared to conventional processed meat. Moreover, the health implications of the combinations of additives used in cultivated meat products remain largely unknown and require further investigation. In addition, although production costs have decreased substantially in recent years, cultivated meat remains considerably more expensive than conventional meat, limiting its widespread commercial availability.

6. Regulatory Framework and Evidence Gaps

6.1. Current Regulatory Approaches

In the United States, the Food and Drug Administration (FDA) and the Food Safety and Inspection Service (FSIS) of the Department of Agriculture (USDA) jointly regulate food additives in meat products [172, 173]. Under current law, manufacturers are permitted to use a wide range of permitted additives, including phosphates, nitrites, and sodium chloride, in poultry and pork meat products without being required to fully disclose their quantitative composition on the label [174]. Labeling requirements are limited to listing ingredients in descending order of weight, which does not provide consumers with accurate information about the concentration of specific substances in the product. As a result, the vast majority of consumers are unable to assess their dietary exposure to these compounds (Figure 5) [174, 175].

FIGURE 5.

FIGURE 5

Regulatory Limits vs. Estimated Additive Exposures A bar chart comparing EU/US regulatory limits for phosphates, nitrites, and sodium with estimated intakes in high consumers, highlighting exposure excesses and the need for RCTs.

The European Union regulatory system is more detailed: Regulation (EC) No 1333/2008 sets maximum permissible levels (MRLs) for phosphates and nitrites in different categories of meat products, and Regulation (EC) No 1169/2011 regulates consumer information [176, 177]. Despite this, the current regulatory framework has several limitations: the MRLs set relate to individual products and do not account for the total daily intake of these compounds from all food sources simultaneously. Since phosphates and nitrites are widely present not only in processed meat but also in soft drinks, dairy products, bakery products, and food supplements, the actual dietary exposure of the consumer may significantly exceed safe levels, even if each individual product formally complies with the established standards (Figure 5) [178]. This fragmentation of regulation effectively makes it challenging to accurately assess the overall risk for the population.

6.2. Evidence Gaps and Methodological Limitations

Limitations in the current evidence base and accumulated epidemiological data: none of the existing regulatory systems provides for the assessment of the potential effects of food additives on the immune system or mental health [179, 180, 181]. Meanwhile, some studies indicate a possible role for excess phosphate in modulating the immune response by altering dendritic cell function, and excess sodium is associated with the activation of Th17 lymphocytes and increased autoimmune responses. These areas remain outside the scope of current regulation due to insufficient evidence. Most of these findings originate from animal experiments and mechanistic in vitro studies, whereas confirmation in large human studies remains limited [182, 183, 184].

A fundamental methodological problem is the critical shortage of randomized controlled trials (RCTs) on the long‐term effects of food additives [185, 186]. Conducting such studies in food nutrition is associated with well‐known ethical and practical difficulties: the impossibility of controlling diet over a long period, low participant compliance, and significant variability in individual metabolism [182, 187]. The available evidence base is mainly based on cohort and case‐control studies, which allow to detect statistical associations between the level of consumption of certain substances and the risk of adverse health outcomes, but cannot establish a cause‐and‐effect relationship [188, 189]. Significant limitations of observational studies are residual confounding, errors in dietary history, and the inability to isolate the effect of a single supplement from the overall dietary pattern (Table 3).

TABLE 3.

Current regulatory limits versus estimated exposures.

Additive EU regulatory limit US regulatory allowance Estimated intake in high consumers
Phosphates [173, 176, 177] 40–70 mg/kg bw/day (ADI) Allowed in brines (≤0.5%) >1000 mg/day
Nitrites [173, 176, 177] 150 mg/kg in meat Up to 200 ppm >2x ADI
Sodium [173, 176, 177] <2 g/day recommended No strict cap 3–5 g/day
Water [173, 176, 177] No limit Permitted if labeled Adds 15%–30% weight

Also worthy of special attention is the lack of standardized biomarkers to assess the chronic effects of phosphates and nitrites on the human body under real‐life nutritional conditions. Without validated exposure indicators, it is impossible to correctly verify doses in clinical trials and to set thresholds for regulatory purposes.

Most available data are derived from observational studies, which are subject to residual confounding, measurement error in dietary assessment, and limited ability to isolate the effects of individual additives

6.3. Prospects for Improving the Regulatory Framework

The identified gaps highlight the need for a fundamental rethinking of approaches to regulating food additives in meat products. First, regulators need to move from assessing the safety of individual products to a cumulative analysis of the total daily and long‐term exposure from all food sources of a substance, an approach already partially implemented by EFSA but requiring further operationalization. Second, labeling requirements need to be significantly strengthened: consumers should have access to quantitative information on the content of key additives, not just their presence in the product. Third, overcoming methodological limitations requires developing new study designs that combine Mendelian randomization, systems biology, and gut microbiome analysis to establish causal relationships between dietary exposures and clinical outcomes. Only a comprehensive scientific approach that integrates epidemiological observations, controlled experimental models, and multisystem assessment of effects—including metabolic, immune, and neurological—can provide the basis for developing evidence‐based regulatory standards and effective consumer education strategies.

It should be noted that regulatory limits for food additives are established based on toxicological safety assessments. Moderate consumption of processed meat within recommended dietary patterns is generally considered acceptable for the general population.

7. Conclusions

Available evidence suggests that water‐binding additives used in processed meat products may have an impact on human health through several biological pathways. These include possible effects on mineral metabolism, oxidative stress, blood pressure regulation, and gut microbiota composition. However, most current data come from observational and experimental studies, and clear cause‐and‐effect relationships have not been fully established.

The combined intake of phosphates, nitrites, and sodium from different food sources may be important, as their effects can interact. At the same time, individual risk may vary depending on overall diet, lifestyle, and pre‐existing health conditions. Certain groups, such as people with cardiovascular or kidney diseases, may be more sensitive to these exposures.

Cultivated meat has been proposed as a potential alternative that may reduce some risks associated with traditional processed meat. It allows for more controlled production conditions and may offer opportunities to optimize or limit the use of certain additives. However, it is important to note that water‐binding agents are often still required in these products to achieve acceptable texture and stability. Therefore, the potential health benefits of cultivated meat remain uncertain and depend on formulation and regulation.

Current regulatory systems mainly evaluate additives separately and at the level of individual products. This approach may not fully reflect real‐life dietary patterns, where multiple sources contribute to total intake. In addition, limited quantitative information on food labels can make it difficult for consumers to assess their exposure.

Future research should focus on the long‐term and combined effects of these additives, using more advanced and integrated approaches. Improving transparency in labeling and considering cumulative intake could support better risk assessment and more informed dietary choices.

Funding

This work was supported by seed funding from the Norwegian University of Science and Technology (NTNU).

Contributor Information

Pavlo Petakh, Email: pavlo.petakh@uzhnu.edu.ua.

Denis E. Kainov, Email: denis.kainov@ntnu.no.

Data Availability Statement

The authors have nothing to report

References

  • 1. Szeląg‐Sikora A., Oleksy‐Gębczyk A., Rydwańska P., Kowalska‐Jarnot K., Kochanek A., and Generowicz A., “Sustainable Food Consumption and the Attitude–Behavior Gap: Factor Analysis and Recommendations for Marketing Communication,” Sustainability 17, no. 21 (2025): 9476, 10.3390/su17219476. [DOI] [Google Scholar]
  • 2. Clonan A., Roberts K. E., and Holdsworth M., “Socioeconomic and Demographic Drivers of Red and Processed Meat Consumption: Implications for Health and Environmental Sustainability,” Proceedings of the Nutrition Society 75, no. 3 (2016): 367–373, 10.1017/S0029665116000100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Molina R. E., Bohrer B. M., and Mejia S. M. V., “Phosphate Alternatives for Meat Processing and Challenges for the Industry: A Critical Review,” Food Research International 166 (2023): 112624, 10.1016/j.foodres.2023.112624. [DOI] [PubMed] [Google Scholar]
  • 4. Gómez I., Janardhanan R., Ibañez F. C., and Beriain M. J., “The Effects of Processing and Preservation Technologies on Meat Quality: Sensory and Nutritional Aspects,” Foods 9, no. 10 (2020): 1416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Sandesh Suresh K. and Kudre T. G., “Chapter 3 ‐ Advances in Meat Processing Technologies and Product development,” in “Research and Technological Advances in Food Science”, ed. Prakash B, (Academic Press, 2022), 61–89, 10.1016/B978-0-12-824369-5.00002-6. [DOI] [Google Scholar]
  • 6. Arokiyaraj S., Dinakarkumar Y., and Shin H., “A Comprehensive Overview on the Preservation Techniques and Packaging of Processed Meat Products: Emphasis on Natural Derivatives,” Journal of King Saud University—Science 36 (2024): 103032, 10.1016/j.jksus.2023.103032. [DOI] [Google Scholar]
  • 7. Bartoń M., Waraczewski R., Muszyński S., Stasiak D. M., and Sołowiej B. G., “Effects of Whey and Plant‐Based Additives on Technological and Microbiological Characterization of Fermented Raw‐Dried Pork Meat Snacks of Human Grade Standard,” Foods 14, no. 22 (2025): 3960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Shangguan S., Afshin A., Shulkin M., et al., “A Meta‐Analysis of Food Labeling Effects on Consumer Diet Behaviors and Industry Practices,” American journal of preventive medicine 56, no. 2 (2019): 300–314, 10.1016/j.amepre.2018.09.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Zec S., Minto C., Agostoni C., et al., “Communicating Risk Regarding Food Consumption: The Case of Processed Meat,” Nutrients 11, no. 2 (2019): 400, 10.3390/nu11020400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Younes M., Aquilina G., Castle L., et al., “Re‐evaluation of Phosphoric Acid–phosphates—di‐, Tri‐ and Polyphosphates (E 338–341, E 343, E 450–452) as Food Additives and the Safety of Proposed Extension of Use,” EFSA Journal 17, no. 6 (2019): e05674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Sancar F., “Agreement to Regulate Cell‐Based Meat Products,” Jama 321 (2019): 1449, 10.1001/jama.2019.3831. [DOI] [PubMed] [Google Scholar]
  • 12. Lampen A., Lachenmeier D. W., Diel P., et al., “Dietary Phosphate Exposure–strategies to Protect Vulnerable Population Groups,” Archives of Toxicology (2026): 1657–1684, 10.1007/s00204-025-04274-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Seto T., Grondin J. A., and Khan W. I., “Food Additives: Emerging Detrimental Roles on Gut Health,” The FASEB Journal 39, no. 13 (2025): 70810, 10.1096/fj.202500737R. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Witkowski M., Grajeta H., and Gomułka K., “Hypersensitivity Reactions to Food Additives—Preservatives, Antioxidants, Flavor Enhancers,” International journal of environmental research and public health 19, no. 18 (2022): 11493, 10.3390/ijerph191811493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Martínez‐Heredia L., Canelo‐Moreno J. M., García‐Fontana B., and Muñoz‐Torres M., “Non‐Classical Effects of FGF23: Molecular and Clinical Features,” International journal of molecular sciences 25, no. 9 (2024): 4875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Vranić D., Milešević J., Trbović D., et al., “Exposure to Phosphates and Nitrites Through Meat Products: Estimation of the Potential Risk to Pregnant Women,” Nutrients 15, no. 12 (2023): 2777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Buller I. D., Patel D. M., Weyer P. J., Prizment A., Jones R. R., and Ward M. H., “Ingestion of Nitrate and Nitrite and Risk of Stomach and Other Digestive System Cancers in the Iowa Women's Health Study,” International Journal of Environmental Research and Public Health 18, no. 13 (2021): 6822, 10.3390/ijerph18136822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Kazi R. N. A., “Silent Effects of High Salt: Risks beyond Hypertension and Body's Adaptation to High Salt,” Biomedicines 13, no. 3 (2025): 746, 10.3390/biomedicines13030746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Repchuk Y., Sydorchuk L., Andrii S., et al., “Linkage of Blood Pressure, Obesity and Diabetes Mellitus With Angiotensinogen Gene (AGT 704T>C/rs699) Polymorphism in Hypertensive Patients,” Bratislava Medical Journal 122 (2021): 715–720. [DOI] [PubMed] [Google Scholar]
  • 20. Drenjančević‐Perić I., Jelaković B., Lombard J. H., Kunert M. P., Kibel A., and Gros M., “High‐Salt Diet and Hypertension: Focus on the Renin‐Angiotensin System,” Kidney and Blood Pressure Research 34, no. 1 (2011): 1–11, 10.1159/000320387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Chazelas E., Pierre F., Druesne‐Pecollo N., et al., “Nitrites and Nitrates From Food Additives and Natural Sources and Cancer Risk: Results From the NutriNet‐Santé Cohort,” International journal of epidemiology 51, no. 4 (2022): 1106–1119, 10.1093/ije/dyac046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Qian F., Riddle M. C., Wylie‐Rosett J., and Hu F. B., “Red and Processed Meats and Health Risks: How Strong Is the Evidence?,” Diabetes Care 43, no. 2 (2020): 265–271, 10.2337/dci19-0063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Li‐Hua P. and Bajinka O., “Processed Meat Health Risks: Pathways and Dietary Solutions,” The Journal of nutrition 155, no. 11 (2025): 3584–3594, 10.1016/j.tjnut.2025.08.030. [DOI] [PubMed] [Google Scholar]
  • 24. Bilous I. I., Korda M. M., Krynytska I. Y., and Kamyshnyi A. M., “Nerve Impulse Transmission Pathway‐focused Genes Expression Analysis in Patients With Primary Hypothyroidism and Autoimmune Thyroiditis,” Endocrine regulations 54, no. 2 (2020): 109–118, 10.2478/enr-2020-0013. [DOI] [PubMed] [Google Scholar]
  • 25. Brown R. B. and Mielke J. G., “Carcinogenesis Associated With Toxin Nephropathy: Proposed Mediation by Phosphate Toxicity,” Cells 14, no. 13 (2025): 952, 10.3390/cells14130952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Yin Y., Zhao C., Hua Y., et al., “Exploring the Common Genetic Basis of Metabolic Syndrome‐Related Diseases and Chronic Kidney Disease: Insights From Extensive Genome‐wide Cross‐trait Analyses,” BioData Mining 18, no. 1 (2025): 54, 10.1186/s13040-025-00472-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Godsey T. J., Eden T., and Emerson S. R., “Ultra‐Processed Foods and Metabolic Dysfunction: A Narrative Review of Dietary Processing, Behavioral Drivers and Chronic Disease Risk,” Metabolites 15, no. 12 (2025): 784, 10.3390/metabo15120784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Mirza Alizadeh A., Mohammadi M., Hashempour‐baltork F., Hosseini H., and Shahidi F., “Process‐induced Toxicants in Food: An Overview on Structures, Formation Pathways, Sensory Properties, Safety and Health Implications,” Food Production, Processing and Nutrition 7, no. 1 (2025): 7, 10.1186/s43014-024-00295-9. [DOI] [Google Scholar]
  • 29. Ashwell M., Hickson M., Stanner S., Prentice A., and Williams C. M., “Nature of the Evidence Base and Strengths, Challenges and Recommendations in the Area of Nutrition and Health Claims: A Position Paper From the Academy of Nutrition Sciences,” British Journal of Nutrition 130, no. 2 (2023): 221–238, 10.1017/S0007114522003300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Roobab U., Madni G. M., Ranjha M. M. A. N., et al., “Applications of Water Activated by Ozone, Electrolysis, or Gas Plasma for Microbial Decontamination of Raw and Processed Meat,” Frontiers in Sustainable Food Systems 7 (2023): 2023, 10.3389/fsufs.2023.1007967. [DOI] [Google Scholar]
  • 31. Tang J., Wu X., Lv D., Huang S., Zhang Y., and Kong F., “Effect of Salt Concentration on the Quality and Microbial Community During Pickled Peppers Fermentation,” Food Chemistry: X 23 (2024): 101594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Vraalstad V., Postelmans A., O'Farrell M., Tschudi J., Wold J. P., and Saeys W., “Understanding the Impact of Drying on the Optical Properties of Cured Muscle Tissue: A Case Study of Dried Salt‐Cured Cod,” Food and Bioprocess Technology 18, no. 11 (2025): 9392–9408, 10.1007/s11947-025-03985-5. [DOI] [Google Scholar]
  • 33. Ali I. M., Forsido S. F., Kuyu C. G., et al., “Effects of Extrusion Process Conditions on Nutritional, Anti‐Nutritional, Physical, Functional, and Sensory Properties of Extruded Snack: A Review,” Food science & nutrition 12, no. 11 (2024): 8755–8761, 10.1002/fsn3.4472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Ahrné L., Chen H., Henry C. J., Kim H. S., Schneeman B., and Windhab E. J., “Defining the Role of Processing in Food Classification Systems‐the IUFoST Formulation & Processing Approach,” NPJ science of food 9, no. 1 (2025): 56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Błaszczyk J. W., “Metabolites of Life: Phosphate,” Metabolites 13, no. 7 (2023): 860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Michel M., Eldridge A. L., Hartmann C., Klassen P., Ingram J., and Meijer G. W., “Benefits and Challenges of Food Processing in the Context of Food Systems, Value Chains and Sustainable Development Goals,” Trends in Food Science & Technology 153 (2024): 104703, 10.1016/j.tifs.2024.104703. [DOI] [Google Scholar]
  • 37. Sawant S. S., Park H.‐Y., Sim E.‐Y., Kim H.‐S., and Choi H.‐S., “Microbial Fermentation in Food: Impact on Functional Properties and Nutritional Enhancement—A Review of Recent Developments,” Fermentation 11, no. 1 (2025): 15, 10.3390/fermentation11010015. [DOI] [Google Scholar]
  • 38. Han L., Hu T., Huang M., et al., “Oxidation‐induced Structural Modifications and Their Impact on Water Retention in Yak Meat Proteins Across pH and NaCl Gradients,” LWT 245 (2026): 119160, 10.1016/j.lwt.2026.119160. [DOI] [Google Scholar]
  • 39. Xue C., Pei Z., Wen P., Chin Y., and Hu Y., “Effects of pH and NaCl on the Spatial Structure and Conformation of Myofibrillar Proteins and the Emulsion Gel System—Insights From Computational Molecular Dynamics on Myosin of Golden Pompano,” Gels 9, no. 4 (2023): 270, 10.3390/gels9040270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Wang J., Yang P., Han D., et al., “Role of Intramuscular Connective Tissue in Water Holding Capacity of Porcine Muscles,” Foods 11, no. 23 (2022): 3835, 10.3390/foods11233835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Gil M., Rudy M., Stanisławczyk R., and Duma‐Kocan P., “Effect of Traditional Cooking and Sous Vide Heat Treatment, Cold Storage Time and Muscle on Physicochemical and Sensory Properties of Beef Meat,” Molecules 27, no. 21 (2022): 7307, 10.3390/molecules27217307, (Basel, Switzerland). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Uchiyama‐Tanaka Y., “Chronic Kidney Disease and Diet,” Renal Replacement Therapy 11, no. 1 (2025): 71, 10.1186/s41100-025-00668-x. [DOI] [Google Scholar]
  • 43. Zając M. and Szram R., “Evaluation of no Synthase Activity in Meat‐Brining Solutions: Implications for Meat Curing and Color Stability,” Molecules 30, no. 6 (2025): 1215, 10.3390/molecules30061215, (Basel, Switzerland). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Zhang Y., Zhang Y., Jia J., et al., “Nitrite and Nitrate in Meat Processing: Functions and Alternatives,” Current Research in Nutrition and Food Science Journal 6 (2023): 100470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Ferysiuk K. and Wójciak K. M., “Reduction of Nitrite in Meat Products Through the Application of Various Plant‐Based Ingredients,” Antioxidants 9, no. 8 (2020): 711, 10.3390/antiox9080711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Shakil M. H., Trisha A. T., Rahman M., et al., “Nitrites in Cured Meats, Health Risk Issues, Alternatives to Nitrites: A Review,” Foods 11, no. 21 (2022): 3355, 10.3390/foods11213355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Urban‐Chmiel R., Osek J., and Wieczorek K., “Methods of Controlling Microbial Contamination of Food,” Pathogens 14, no. 5 (2025): 492, 10.3390/pathogens14050492, (Basel, Switzerland). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Karwowska M. and Kononiuk A., “Nitrates/Nitrites in Food—Risk for Nitrosative Stress and Benefits,” Antioxidants 9, no. 3 (2020): 241, 10.3390/antiox9030241, (Basel, Switzerland). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Xie Y., Geng Y., Yao J., et al., “N‐nitrosamines in Processed Meats: Exposure, Formation and Mitigation Strategies,” Journal of Agriculture and Food Research 13 (2023): 100645, 10.1016/j.jafr.2023.100645. [DOI] [Google Scholar]
  • 50. Kim M., Bae S. M., Yoo Y., Park J., and Jeong J. Y., “Clean‐Label Strategies for the Replacement of Nitrite, Ascorbate, and Phosphate in Meat Products: A Review,” Foods 14, no. 14 (2025): 2442, 10.3390/foods14142442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Andrade B. F., Carmo L. R. D., Tanaka M. S., Filho R. A. T., Ramos A. L. S., and Ramos E. M., “Evaluation of Nonthermal Technologies to Reduce or Replace Nitrite in Meat Products,” Food technology and biotechnology 63, no. 1 (2025): 94, 10.17113/ftb.63.01.25.8744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Zhang Z., Xu G., and Hu S., “A Comprehensive Review on the Recent Technological Advancements in the Processing, Safety, and Quality Control of Ready‐to‐Eat Meals,” Processes 13, no. 3 (2025): 901, 10.3390/pr13030901. [DOI] [Google Scholar]
  • 53. Arshad Z., Shahid S., Hasnain A., Yaseen E., and Rahimi M., “Functional Foods Enriched with Bioactive Compounds: Therapeutic Potential and Technological Innovations,” Food science & nutrition 13, no. 10 (2025): 71024, 10.1002/fsn3.71024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Lee S. H. and Kim H. Y., “Effect of Sodium Nitrite, Sodium Chloride and Concentrated Seawater on Physicochemical Properties of Meat Emulsion System,” Food science of animal resources 40, no. 6 (2020): 980–989, 10.5851/kosfa.2020.e68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Zhu Y., Ding J., Zhang J., and Li L., “Effects of Sodium Phosphate and Sodium Nitrite on the Pitting Corrosion Process of X70 Carbon Steel in Sodium Chloride Solution,” Materials 13, no. 23 (2020): 5392, 10.3390/ma13235392, (Basel, Switzerland). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Škrlep M., Ozmec M., and Čandek‐Potokar M., “Reduced Use of Nitrites and Phosphates in Dry‐Fermented Sausages,” Processes 10, no. 5 (2022): 821. [Google Scholar]
  • 57. Elshazly T. M., Bourauel C., Aboushelib M. N., Sherief D. I., and El‐Korashy D. I., “The Polymerization Efficiency of a Bulk‐fill Composite Based on Matrix‐modification Technology,” Restorative dentistry & endodontics 45, no. 3 (2020): e32, 10.5395/rde.2020.45.e32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Fu M., Kumar P., Sazili A. Q., and Ismail‐Fitry M. R., “Application of Functional Ingredients in Meat Products for Appetite Regulation: A Promising Strategy to Address Overconsumption,” Appetite 208 (2025): 107949, 10.1016/j.appet.2025.107949. [DOI] [PubMed] [Google Scholar]
  • 59. Zhang M., Fu C., Chen M., and Jin C., “The Effect of Sodium Chloride on the Physicochemical and Textural Properties and Flavor Characteristics of Sous Vide Cooked Duck Meat,” Foods 12, no. 18 (2023): 3452, 10.3390/foods12183452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Kim T. K., Yong H. I., Jung S., Kim H. W., and Choi Y. S., “Technologies for the Production of Meat Products With a Low Sodium Chloride Content and Improved Quality Characteristics—A Review,” Foods 10, no. 5 (2021): 957, 10.3390/foods10050957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Garner L. J., Brooks L., Spencer L. F., Rehm J., Kataria J., and Morey A., “Effect of Pre‐Blended Phosphates on the Freezing Quality Characteristics of Ground Woody Breast Meat Compared to Normal Meat,” Animals 10, no. 10 (2020): 1880, 10.3390/ani10101880,:an open access journal from MDPI. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Goemaere O., Glorieux S., Govaert M., Steen L., and Fraeye I., “Phosphate Elimination in Emulsified Meat Products: Impact of Protein‐Based Ingredients on Quality Characteristics,” Foods 10, no. 4 (2021): 882, 10.3390/foods10040882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Cobos Á. and Díaz O., Chemical Composition of Meat and Meat Products. in Handbook of Food Chemistry, ed. Cheung P. C. K. and Mehta B. M. (Springer Berlin Heidelberg, 2015), 471–510, 10.1007/978-3-642-36605-5. [DOI] [Google Scholar]
  • 64. Ferysiuk K. and Wójciak K. M., “Reduction of Nitrite in Meat Products Through the Application of Various Plant‐Based Ingredients,” Antioxidants 9, no. 8 (2020): 711, 10.3390/antiox9080711, (Basel, Switzerland). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Ali M., Aung S. H., Abeyrathne E. D. N. S., et al., “Quality Enhancement of Frozen Chicken Meat Marinated With Phosphate Alternatives,” Food Science of Animal Resources 43 (2023): 245–268, 10.5851/kosfa.2022.e72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Ursachi C., Perța‐Crișan S., and Munteanu F. D., “Strategies to Improve Meat Products′ Quality,” Foods 9, no. 12 (2020): 1883, 10.3390/foods9121883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Luo J., Zhang M., Zeng Y., et al., “Structural and Functional Properties of Protein Hydrolysates From Myofibrillar Protein of Crocodile (Crocodylus siamensis) Meat,” LWT 196 (2024): 115862, 10.1016/j.lwt.2024.115862. [DOI] [Google Scholar]
  • 68. Ritz E., Hahn K., Ketteler M., Kuhlmann M. K., and Mann J., “Phosphate Additives in Food–A Health Risk,” Deutsches Arzteblatt international 109, no. 4 (2012): 49–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Raju S. and Saxena R., “Hyperphosphatemia in Kidney Failure: Pathophysiology, Challenges, and Critical Role of Phosphorus Management,” Nutrients 17, no. 9 (2025): 1587, 10.3390/nu17091587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. González‐García N., Hospital‐Sastre A., Fernández‐Villabrille S., et al., “The Impact of Hyperphosphatemia on Mineral and Bone Metabolism: Implications for Bone and Vascular Health,” International journal of molecular sciences 27, no. 4 (2026): 1931, 10.3390/ijms27041931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Vardhan A. and Hutchison A. J., Calcium, Phosphate, and Renal Osteodystrophyed. in Nolph and Gokal's Textbook of Peritoneal Dialysis ed. Khanna R. and Krediet R. T. (Springer International Publishing, 2023), 537–573, 10.1007/978-3-030-62087-5. [DOI] [Google Scholar]
  • 72. Burns‐Whitmore B., Froyen E. B., and Isom K. A., “Vitamin D and Calcium—An Overview, Review of Metabolism, and the Importance of Co‐Supplementation,” Dietetics 3, no. 4 (2024): 588–608, 10.3390/dietetics3040040. [DOI] [Google Scholar]
  • 73. Cao G., Xuan X., Hu J., Zhang R., Jin H., and Dong H., “How Vascular Smooth Muscle Cell Phenotype Switching Contributes to Vascular Disease,” Cell Communication and Signaling 20, no. 1 (2022): 180, 10.1186/s12964-022-00993-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Cozzolino M., Ciceri P., Galassi A., et al., “The Key Role of Phosphate on Vascular Calcification,” Toxins 11, no. 4 (2019): 213, 10.3390/toxins11040213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Lee S. J., Lee I. K., and Jeon J. H., “Vascular Calcification—New Insights Into Its Mechanism,” International Journal of Molecular Sciences 21, no. 8 (2020): 2685, 10.3390/ijms21082685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Lacerda‐Abreu M. A. and Meyer‐Fernandes J. R., “Hyperphosphataemia and NADPH Oxidase Regulation in Pathophysiological Processes: Implications for Oxidative Stress and Disease Progression,” Antioxidants 14, no. 4 (2025): 461, 10.3390/antiox14040461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Ragni M., Ruocco C., and Nisoli E., “Mitochondrial Uncoupling, Energy Substrate Utilization, and Brown Adipose Tissue as Therapeutic Targets in Cancer,” npj metabolic health and disease 3, no. 1 (2025): 37, 10.1038/s44324-025-00080-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Bilous I., Pavlovych L., Krynytska I., Marushchak M., and Kamyshnyi O., “Apoptosis and Cell Cycle Pathway‐Focused Genes Expression Analysis in Patients With Different Forms of Thyroid Pathology,” Open Access Macedonian Journal of Medical Sciences 8, no. B (2020): 784–792, 10.3889/oamjms.2020.4760. [DOI] [Google Scholar]
  • 79. Juan C. A., Pérez de la Lastra J. M., Plou F. J., and Pérez‐Lebeña E., “The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies,” International journal of molecular sciences 22, no. 9 (2021): 4642, 10.3390/ijms22094642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Andrés C. M. C., Pérez de la Lastra J. M., Andrés Juan C., Plou F. J., and Pérez‐Lebeña E., “Superoxide Anion Chemistry‐Its Role at the Core of the Innate Immunity,” International journal of molecular sciences 24, no. 3 (2023): 1841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Halabitska I., Oksenych V., and Kamyshnyi O., “Exploring the Efficacy of Alpha‐Lipoic Acid in Comorbid Osteoarthritis and Type 2 Diabetes Mellitus,” Nutrients 16, no. 19 (2024): 3349, 10.3390/nu16193349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Drzewoski J. and Hanefeld M., “The Current and Potential Therapeutic Use of Metformin—The Good Old Drug,” Pharmaceuticals 14, no. 2 (2021): 122, 10.3390/ph14020122, (Basel, Switzerland). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Huang X., Huang L., Lu J., et al., “The Relationship Between Telomere Length and Aging‐related Diseases,” Clinical and Experimental Medicine 25, no. 1 (2025): 72, 10.1007/s10238-025-01608-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Halabitska I., Petakh P., Oksenych V., and Kamyshnyi O., “Predictive Analysis of Osteoarthritis and Chronic Pancreatitis Comorbidity: Complications and Risk Factors,” Frontiers in endocrinology 15 (2024): 1492741, 10.3389/fendo.2024.1492741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Liu S., Liu J., Wang Y., Deng F., and Deng Z., “Oxidative Stress: Signaling Pathways, Biological Functions, and Disease,” MedComm 6, no. 7 (2025): 70268, 10.1002/mco2.70268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Yuan T., Yang T., Chen H., et al., “New Insights Into Oxidative Stress and Inflammation During Diabetes Mellitus‐accelerated Atherosclerosis,” Redox biology 20 (2019): 247–260, 10.1016/j.redox.2018.09.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Bilous I. I., Pavlovych L. L., and Kamyshnyi A. M., “Primary Hypothyroidism and Autoimmune Thyroiditis Alter the Transcriptional Activity of Genes Regulating Neurogenesis in the Blood of Patients,” Endocrine regulations 55, no. 1 (2021): 5–15, 10.2478/enr-2021-0002. [DOI] [PubMed] [Google Scholar]
  • 88. Jaques D. A., Wuerzner G., and Ponte B., “Sodium Intake as a Cardiovascular Risk Factor: A Narrative Review,” Nutrients 13, no. 9 (2021): 3177, 10.3390/nu13093177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89. Salazar‐Ulbrich N., Haro‐Solis D., Aguayo F., et al., “Genotoxic Bacteria and Oncogenic Viruses in Colorectal Cancer: Evidence, Gaps, and a Proposed Interaction Model,” International journal of molecular sciences 27, no. 5 (2026): 2272, 10.3390/ijms27052272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Borrelli S., Provenzano M., Gagliardi I., et al., “Sodium Intake and Chronic Kidney Disease,” International journal of molecular sciences 21, no. 13 (2020): 4744, 10.3390/ijms21134744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Nagasawa Y., “Positive and Negative Aspects of Sodium Intake in Dialysis and Non‐Dialysis CKD Patients,” Nutrients 13, no. 3 (2021): 951, 10.3390/nu13030951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92. Oppelaar J. J. and Vogt L., “Body Fluid‐Independent Effects of Dietary Salt Consumption in Chronic Kidney Disease,” Nutrients 11, no. 11 (2019): 2779, 10.3390/nu11112779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93. Citterio L., El Boustani M., Simonini M., Manunta P., and Lanzani C., “Epigenetic Mechanisms of Salt‐Sensitive Hypertension,” Clinical kidney journal 18, no. 11 (2025): sfaf307, 10.1093/ckj/sfaf307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Polychronopoulou E., Braconnier P., and Burnier M., “New Insights on the Role of Sodium in the Physiological Regulation of Blood Pressure and Development of Hypertension,” Frontiers in cardiovascular medicine 6 (2019): 136, 10.3389/fcvm.2019.00136, ‐ 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95. Erichsen D. W., Bondonno N. P., Pokharel P., et al., “Source‐Specific Nitrate and Nitrite Intake and Association With Colorectal Cancer in the Danish Diet, Cancer and Health Cohort,” Environment International 202 (2025): 109658, 10.1016/j.envint.2025.109658. [DOI] [PubMed] [Google Scholar]
  • 96. Mocan D., Jipa R., Jipa D. A., et al., “Unveiling the Systemic Impact of Congestion in Heart Failure: A Narrative Review of Multisystem Pathophysiology and Clinical Implications,” Journal of cardiovascular development and disease 12, no. 4 (2025): 124, 10.3390/jcdd12040124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97. Gupta D., Brietzke S., Hayden M. R., Kurukulasuriya L. R., and Sowers J. R., “Phosphate Metabolism in Cardiorenal Metabolic Disease,” Cardiorenal medicine 1, no. 4 (2011): 261–270, 10.1159/000332388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98. Rivera R. F., Sciarrone Alibrandi M. T., Foligno N. E., Magagnoli L., Ciceri P., and Cozzolino M., “Uremic Toxin‐Driven Vascular Calcification in Chronic Kidney Disease: Molecular Pathways and Integrated Phenotypes,” Toxins 18, no. 2 (2026): 112, 10.3390/toxins18020112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99. Rot T., Kovačević D., Habschied K., and Mastanjević K., “N‐Nitrosamines in Meat Products: Formation, Detection and Regulatory Challenges,” Processes 13, no. 5 (2025): 1555, 10.3390/pr13051555. [DOI] [Google Scholar]
  • 100. González A., Odriozola I., Fullaondo A., and Odriozola A., “Chapter Six—Microbiota and Detrimental Protein Derived Metabolites in Colorectal cancer,” in “Advances in Genetics”, ed. Martínez A. O., (Academic Press, 2024), 255–308. [DOI] [PubMed] [Google Scholar]
  • 101. Si W., Zhao Y., Wu Y., et al., “High‐Salt Diets, Intestinal Barrier, and Hypertension: A Mechanistic Review and the Promise of Dietary Therapy,” Nutrients 17, no. 23 (2025): 3688, 10.3390/nu17233688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102. Wang L. and Hu J., “Unraveling the Gut Microbiota's Role in Salt‐sensitive Hypertension: Current Evidences and Future Directions,” Frontiers in cardiovascular medicine 11 (2024): 1410623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103. Golonka R. M., Cooper J. K., Issa R., et al., “Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the Gut‐Liver Axis,” Current Hypertension Reports 23, no. 5 (2021): 28, 10.1007/s11906-021-01142-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104. Gómez I., Janardhanan R., Ibañez F. C., and Beriain M. J., “The Effects of Processing and Preservation Technologies on Meat Quality: Sensory and Nutritional Aspects,” Foods 9, no. 10 (2020): 1416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105. Mirzababaei A., Mahmoodi M., Abaj F., et al., “The Association of Dietary Nitrates/Nitrites Intake and the Gut Microbial Metabolite Trimethylamine N‐oxide and Kynurenine in Adults: A Population‐based Study,” Frontiers in nutrition 11 (2024): 1346074, 10.3389/fnut.2024.1346074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106. Henein M. Y., Vancheri S., Longo G., and Vancheri F., “The Role of Inflammation in Cardiovascular Disease,” International journal of molecular sciences 23, no. 21 (2022): 12906, 10.3390/ijms232112906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107. Amaritei O., Mierlan O. L., Dinu C. A., et al., “TMAO and Cardiovascular Disease: Exploring Its Potential as a Biomarker,” Medicina 61, no. 10 (2025): 1767, 10.3390/medicina61101767, (Kaunas, Lithuania). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108. Budoff M. J., de Oliveira Otto M. C., Li X. S., et al., “Trimethylamine‐N‐oxide (TMAO) and Risk of Incident Cardiovascular Events in the Multi Ethnic Study of Atherosclerosis,” Scientific reports 15, no. 1 (2025): 23362, 10.1038/s41598-025-05903-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109. Fuhren J., Schwalbe M., Boekhorst J., Rösch C., Schols H. A., and Kleerebezem M., “Dietary Calcium Phosphate Strongly Impacts Gut Microbiome Changes Elicited by Inulin and Galacto‐oligosaccharides Consumption,” Microbiome 9, no. 1 (2021): 218, 10.1186/s40168-021-01148-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110. Ye G., Yang W., Bi Z., Huang L., and Liu F., “Effects of a High‐phosphorus Diet on the Gut Microbiota in CKD Rats,” Renal failure 43, no. 1 (2021): 1577–1587, 10.1080/0886022X.2021.2003207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111. Oda N., Sugihara K., Uebanso T., et al., “Dietary Phosphate Disturbs of Gut Microbiome in Mice,” Journal of Clinical Biochemistry and Nutrition 73, no. 3 (2023): 221–227, 10.3164/jcbn.23-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112. Sarkar A., McInroy C. J. A., Harty S., et al., “Microbial Transmission in the Social Microbiome and Host Health and Disease,” Cell 187, no. 1 (2024): 17–43, 10.1016/j.cell.2023.12.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113. Almansour N., Al‐Rashed F., Choudhry K., et al., “Gut Microbiota: A Promising New Target in Immune Tolerance,” Frontiers in Immunology 16 (2025): 1607388, 10.3389/fimmu.2025.1607388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114. Wang X., Lang F., and Liu D., “High‐Salt Diet and Intestinal Microbiota: Influence on Cardiovascular Disease and Inflammatory Bowel Disease,” Biology 13, no. 9 (2024): 674, 10.3390/biology13090674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115. Luo T., Ji W.‐J., Yuan F., et al., “Th17/Treg Imbalance Induced by Dietary Salt Variation Indicates Inflammation of Target Organs in Humans,” Scientific Reports 6, no. 1 (2016): 26767, 10.1038/srep26767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116. Yasmeen F., Pirzada R. H., Ahmad B., Choi B., and Choi S., “Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies,” International journal of Molecular Sciences 25, no. 14 (2024): 7666, 10.3390/ijms25147666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117. Song Y., Li J., and Wu Y., “Evolving Understanding of Autoimmune Mechanisms and New Therapeutic Strategies of Autoimmune Disorders,” Signal Transduction and Targeted Therapy 9, no. 1 (2024): 263, 10.1038/s41392-024-01952-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118. Xiang Y., Zhang M., Jiang D., Su Q., and Shi J., “The Role of Inflammation in Autoimmune Disease: A Therapeutic Target,” Frontiers in Immunology 14 (2023): 1267091, 10.3389/fimmu.2023.1267091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119. Halabitska I., Petakh P., and Kamyshnyi O., “Metformin as a Disease‐modifying Therapy in Osteoarthritis: Bridging Metabolism and Joint Health,” Frontiers in Pharmacology 16 (2025): 1567544, 10.3389/fphar.2025.1567544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120. Sankarganesh P., Bhunia A., Ganesh Kumar A., Babu A. S., Gopukumar S. T., and Lokesh E., “Short‐chain Fatty Acids (SCFAs) in Gut Health: Implications for Drug Metabolism and Therapeutics,” Medicine in Microecology 25 (2025): 100139, 10.1016/j.medmic.2025.100139. [DOI] [Google Scholar]
  • 121. Buchynskyi M., Kamyshna I., Halabitska I., et al., “Unlocking the Gut‐liver Axis: Microbial Contributions to the Pathogenesis of Metabolic‐associated Fatty Liver Disease,” Frontiers in Microbiology 16 (2025): 1577724, 10.3389/fmicb.2025.1577724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122. Hays K. E., Pfaffinger J. M., and Ryznar R., “The Interplay Between Gut Microbiota, Short‐chain Fatty Acids, and Implications for Host Health and Disease,” Gut Microbes 16, no. 1 (2024): 2393270, 10.1080/19490976.2024.2393270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123. Long C., Zhou X., Xia F., and Zhou B., “Intestinal Barrier Dysfunction and Gut Microbiota in Non‐Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations,” Biology 13, no. 4 (2024): 243, 10.3390/biology13040243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124. Halabitska I., Petakh P., Lushchak O., Kamyshna I., Oksenych V., and Kamyshnyi O., “Metformin in Antiviral Therapy: Evidence and Perspectives,” Viruses 16, no. 12 (2024): 1938, 10.3390/v16121938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125. Zhang Y., Liu Y., Liang X., et al., “Intestinal Barrier in Chronic Gut and Liver Diseases: Pathogenesis and Therapeutic Targets,” Acta Pharmaceutica Sinica B 15, no. 11 (2025): 5515–5536, 10.1016/j.apsb.2025.08.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126. Kamel M., Aleya S., Alsubih M., and Aleya L., “Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases,” Journal of Personalized Medicine 14, no. 2 (2024): 217, 10.3390/jpm14020217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127. Zhou X., Wu Y., Zhu Z., et al., “Mucosal Immune Response in Biology, Disease Prevention and Treatment,” Signal transduction and targeted therapy 10, no. 1 (2025): 7, 10.1038/s41392-024-02043-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128. Crowe W., Pan X., Mackle J., et al., “Dietary Inclusion of Nitrite‐containing Frankfurter Exacerbates Colorectal Cancer Pathology and Alters Metabolism in APCmin Mice,” npj Science of Food 6, no. 1 (2022): 60, 10.1038/s41538-022-00174-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129. Marrella V., Nicchiotti F., and Cassani B., “Microbiota and Immunity During Respiratory Infections: Lung and Gut Affair,” International Journal of Molecular Sciences 25, no. 7 (2024): 4051, 10.3390/ijms25074051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130. Iliev I. D., “Mycobiota–host Immune Interactions in IBD: Coming out of the Shadows,” Nature Reviews Gastroenterology & Hepatology 19, no. 2 (2022): 91–92, 10.1038/s41575-021-00541-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131. Marascio N., Pavia G., Brescia B., et al., “Prevalence of Enteric Pathogens and Antibiotic Resistance: Results of a Six‐Year Active Surveillance Study on Patients Admitted to a Teaching Hospital,” Antibiotics 13, no. 8 (2024): 726, 10.3390/antibiotics13080726, (Basel, Switzerland). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132. Liu G., Li C.‐M., Xie F., et al., “Colorectal Cancer's Burden Attributable to a Diet High in Processed Meat in the Belt and Road Initiative Countries,” World journal of gastrointestinal oncology 16, no. 1 (2024): 182–196, 10.4251/wjgo.v16.i1.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133. Ungvari Z., Fekete M., Varga P., et al., “Association Between Red and Processed Meat Consumption and Colorectal Cancer Risk: A Comprehensive Meta‐analysis of Prospective Studies,” GeroScience 47, no. 3 (2025): 5123–5140, 10.1007/s11357-025-01646-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134. Niedermaier T., Gredner T., Hoffmeister M., Mons U., and Brenner H., “Impact of Reducing Intake of Red and Processed Meat on Colorectal Cancer Incidence in Germany 2020 to 2050—A Simulation Study,” Nutrients 15, no. 4 (2023): 1020, 10.3390/nu15041020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135. Badero O. J., Ikedionwu O. I., Ajayi V., and Jemiseye A. V., “A Review of Susceptibility Factors for Colibactin‐Associated Colorectal Cancer in African Populations,” Cureus 17, no. 11 (2025): 96473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136. Diakité M. T., Diakité B., Koné A., et al., “Relationships Between Gut Microbiota, Red Meat Consumption and Colorectal Cancer,” Journal of Carcinogenesis & Mutagenesis 13, no. 3 (2022): 1000385. [PMC free article] [PubMed] [Google Scholar]
  • 137. Tudosie M. S., Pauna A., Stefani C., and Staicu I. M., “Diet and Food Chemicals Increasing the Risk of Colorectal Cancer—Literature Review,” Journal of Mind and Medical Sciences 9, no. 1 (2022): 118–124, 10.22543/7674.91.P118124. [DOI] [Google Scholar]
  • 138. International Agency for Research on C . Red Meat and Processed Meat (International Agency for Research on Cancer, 2018). [PubMed] [Google Scholar]
  • 139. Torrijo‐Belanche C., Moreno‐Franco B., Muñoz‐Cabrejas A., et al., “High Serum Phosphate Is Associated With Cardiovascular Mortality and Subclinical Coronary Atherosclerosis: Systematic Review and Meta‐Analysis,” Nutrients 16, no. 11 (2024): 1599, 10.3390/nu16111599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140. Rubio‐Aliaga I. and Krapf R., “Phosphate Intake, Hyperphosphatemia, and Kidney Function,” Pflügers Archiv—European Journal of Physiology 474, no. 8 (2022): 935–947, 10.1007/s00424-022-02691-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141. Novillo‐Sarmiento C., García‐Sáez R. M., Rivas‐Domínguez A., et al., “Phosphate and Inflammation in Health and Kidney Disease,” International journal of molecular sciences 27, no. 1 (2026): 408, 10.3390/ijms27010408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142. Liang Z. and Zhang L., “Chronic Inflammation as a Driving Factor for Sarcopenia: An Update on Pathophysiology and Future Therapeutic Targets,” Frontiers in pharmacology 13, no. 3 (2026): 1000385, 10.3389/fphar.2026.1733798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143. Wang Y. J., Yeh T. L., Shih M. C., Tu Y. K., and Chien K. L., “Dietary Sodium Intake and Risk of Cardiovascular Disease: A Systematic Review and Dose‐Response Meta‐Analysis,” Nutrients 12, no. 10 (2020): 2934, 10.3390/nu12102934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144. Evans B. R., Yerly A., van der Vorst E. P. C., et al., “Inflammatory Mediators in Atherosclerotic Vascular Remodeling,” Frontiers in Cardiovascular Medicine 9 (2022): 868934, 10.3389/fcvm.2022.868934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145. Lillo M. A., Burboa P. C., and Durán W. N., “Active Endothelial Inactivation of Hyperpermeability: The Role of Nitric Oxide‐Driven cAMP/Epac1 Signaling,” Journal of Cardiovascular Development and Disease 12, no. 9 (2025): 361, 10.3390/jcdd12090361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146. Chen L., Luo S., Feng M., et al., “Decoding the Link Between Ischemic Stroke and Myocardial Infarction: A Pathophysiological and Clinical Perspective,” European Journal of Medical Research 30, no. 1 (2025): 984, 10.1186/s40001-025-03221-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147. Gerdanovics A., Stănescu I. C., Mîrza C. M., et al., “Proinflammatory Risk Factors in Patients With Ischemic Stroke: A Systematic Review and Meta‐Analysis,” Antioxidants 14, no. 10 (2025): 1229, 10.3390/antiox14101229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148. Dicken S. J., Jassil F. C., Brown A., et al., “Ultraprocessed or Minimally Processed Diets Following Healthy Dietary Guidelines on Weight and Cardiometabolic Health: A Randomized, Crossover Trial,” Nature Medicine 31, no. 10 (2025): 3297–3308, 10.1038/s41591-025-03842-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149. Mironov N., Haque M., Atfi A., and Razzaque M. S., “Phosphate Dysregulation and Metabolic Syndrome,” Nutrients 14, no. 21 (2022): 4477, 10.3390/nu14214477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150. Lane M. M., Gamage E., Travica N., et al., “Ultra‐Processed Food Consumption and Mental Health: A Systematic Review and Meta‐Analysis of Observational Studies,” Nutrients 14, no. 13 (2022): 2568, 10.3390/nu14132568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151. Meiners F., Ortega‐Matienzo A., Fuellen G., and Barrantes I., “Gut Microbiome‐mediated Health Effects of fiber and Polyphenol‐rich Dietary Interventions,” Frontiers in Nutrition 12 (2025): 1647740, 10.3389/fnut.2025.1647740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152. Choe U., “Role of Dietary fiber and Short‐chain Fatty Acids in Preventing Neurodegenerative Diseases Through the Gut‐brain Axis,” Journal of Functional Foods 129 (2025): 106870, 10.1016/j.jff.2025.106870. [DOI] [Google Scholar]
  • 153. Nattagh‐Eshtivani E., Barghchi H., Mansouri A. H., et al., “The Role of Dietary Factors in the Prevention and Management of Inflammatory Bowel Disease: A Comprehensive Review,” Nutrition & Metabolism 22, no. 1 (2025): 157, 10.1186/s12986-025-01068-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 154. Quintieri L., Nitride C., De Angelis E., et al., “Alternative Protein Sources and Novel Foods: Benefits, Food Applications and Safety Issues,” Nutrients 15, no. 6 (2023): 1509, 10.3390/nu15061509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155. Kardas M., Staśkiewicz‐Bartecka W., and Kołodziejczyk A., “Cultured Meat Reformulation: Health Potential and Sustainable Food Challenges—Narrative Review,” Comprehensive reviews in food science and food safety 24, no. 6 (2025): 70262, 10.1111/1541-4337.70262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156. Lin Y.‐C., Wani N. A., Yakir I., et al., “Cultivated Meat for Sustainable Food Security and Environmental Resilience,” Future Foods 13 (2026): 100984, 10.1016/j.fufo.2026.100984. [DOI] [Google Scholar]
  • 157. McDonald L. J., McManus M., and Newnes L., “Is Cultivated Meat Sustainable?—Research Pathways to Cleaner “Clean Meat”,” Cleaner Food Systems 2 (2025): 100007, 10.1016/j.clfs.2025.100007. [DOI] [Google Scholar]
  • 158. Wi G., Bae J., Kim H., Cho Y., and Choi M. J., “Evaluation of the Physicochemical and Structural Properties and the Sensory Characteristics of Meat Analogues Prepared With Various Non‐Animal Based Liquid Additives,” Foods 9, no. 4 (2020): 461, 10.3390/foods9040461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159. Gao Y., Liu R., and Liang H., “Food Hydrocolloids: Structure, Properties, and Applications,” Foods 13, no. 7 (2024): 1077, 10.3390/foods13071077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 160. Li J., Wu Y., Ma Y., Lu N., Regenstein J., and Zhou P., “Effects of Addition of Hydrocolloids on the Textural and Structural Properties of High‐protein Intermediate Moisture Food Model Systems Containing Sodium Caseinate,” Food & Function 8 (2017): 2897–2904, 10.1039/C7FO00570A. [DOI] [PubMed] [Google Scholar]
  • 161. Nie J., Chen D., Yu C., et al., “Differential Effects of Commercial Food‐Grade Carrageenan Preparations on DSS‐Induced Colitis and Gut Microbiota in Mice,” Foods 15, no. 7 (2026): 1131, 10.3390/foods15071131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 162. Kimilu N., Gładyś‐Cieszyńska K., Pieszko M., Mańkowska‐Wierzbicka D., and Folwarski M., “Carrageenan in the Diet: Friend or Foe for Inflammatory Bowel Disease?,” Nutrients 16, no. 11 (2024): 1780, 10.3390/nu16111780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 163. Elias Masiques N., Vermeiren S., De Vrieze J., et al., “Food Hydrocolloids κ‐carrageenan and Xanthan Gum in Processed Red Meat Modify Gut Health in Rats,” Current Research in Food Science 11 (2025): 101162, 10.1016/j.crfs.2025.101162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164. Lee M., Park S., Choi B., et al., “Cultured Meat With Enriched Organoleptic Properties by Regulating Cell Differentiation,” Nature Communications 15, no. 1 (2024): 77, 10.1038/s41467-023-44359-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 165. Jeong D., Jang G., Jung W. K., Park Y. H., and Bae H., “Stretchable Zein‐coated Alginate fiber for Aligning Muscle Cells to Artificially Produce Cultivated Meat,” npj Science of Food 8, no. 1 (2024): 13, 10.1038/s41538-024-00257-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 166. Hassan N., Krieg T., Zinser M., Schröder K., and Kröger N., “An Overview of Scaffolds and Biomaterials for Skin Expansion and Soft Tissue Regeneration: Insights on Zinc and Magnesium as New Potential Key Elements,” Polymers 15, no. 19 (2023): 3854, 10.3390/polym15193854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 167. Bhaskaracharya R. K., Alnuaimi F. S. R., Aldarmaki S. R. J., Abdulazeez A., and Ayyash M., “Labneh: A Retail Market Analysis and Selected Product Characterization,” Foods 13, no. 21 (2024): 3461, 10.3390/foods13213461. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 168. Wang W., Qin X., Chen Z., et al., “Applications of Modified Plant Proteins in Dysphagia‐friendly Foods,” Food Chemistry: X 31 (2025): 103145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 169. Alam A. N., Kim C.‐J., Kim S.‐H., et al., “Trends in Hybrid Cultured Meat Manufacturing Technology to Improve Sensory Characteristics,” Food Science of Animal Resources 44, no. 1 (2024): 39–50, 10.5851/kosfa.2023.e76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 170. Gil M., Rudy M., Duma‐Kocan P., Stanisławczyk R., and Dziki D., “Nutritional, Ethical and Ecological Aspects of Cultured Meat With Particular Emphasis on Functional Food Production: A Comprehensive Literature Review,” Foods 15, no. 5 (2026): 891, 10.3390/foods15050891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 171. Geurs I., Grootaert C., Dewettinck K., Van Vlierberghe S., and Van Camp J., “Engineering Functional Scaffolds and Fat Phases for Cultured Meat,” Future Foods 12 (2025): 100794, 10.1016/j.fufo.2025.100794. [DOI] [Google Scholar]
  • 172. Nollet L. and Ali F., “Food Products Regulations in the United States,” (2024).
  • 173. Institute of M . “National Research Council Committee to Ensure Safe Food From Production to C. The Current US Food Safety System,” in Ensuring Safe Food: From Production to Consumption (National Academies Press (US), 1998). [Google Scholar]
  • 174. Molina J. R. G., Frías‐Celayeta J. M., Bolton D. J., and Botinestean C., “A Comprehensive Review of Cured Meat Products in the Irish Market: Opportunities for Reformulation and Processing,” Foods 13, no. 5 (2024): 746, 10.3390/foods13050746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 175. Kraemer M. V. S., Fernandes A. C., Chaddad M. C. C., Uggioni P. L., and Bernardo G. L., “Proença RPC. Is the List of Ingredients a Source of Nutrition and Health Information in Food Labeling?,” A Scoping Review 15, no. 21 (2023): 4513, Nutrients. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 176.“Regulation (EC) No. 1333/2008 of the European Parliament and of the Council on food additives,” Journal of the European Union L354. (2008):16–33. [Google Scholar]
  • 177.“Regulation (EU) No 1169/2011 on the Provision of Food Information to Consumers,” Official Journal of the European Union L304 (2011):18, https://eur-lex.europa.eu/eli/reg/2011/1169/oj/eng. [Google Scholar]
  • 178. Milešević J., Vranić D., Gurinović M., et al., “The Intake of Phosphorus and Nitrites Through Meat Products: A Health Risk Assessment of Children Aged 1 to 9 Years Old in Serbia,” Nutrients 14, no. 2 (2022): 242, 10.3390/nu14020242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 179. Warner J. O. and Khan A., “Why Is There no Regulation Despite Evidence That Ultra‐processed Foods Are Hazardous to Long‐term Health?,” Future healthcare journal 13, no. 1 (2026): 100503, 10.1016/j.fhj.2026.100503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 180. Zahir A., Ge Z., and Khan I. A., “Public Health Risks Associated With Food Process Contaminants—A Review,” Journal of Food Protection 88, no. 2 (2025): 100426, 10.1016/j.jfp.2024.100426. [DOI] [PubMed] [Google Scholar]
  • 181. Aldabayan Y. S., “Effect of Artificial Food Additives on Lung Health—An Overview,” Medicina 61, no. 4 (2025): 684, 10.3390/medicina61040684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 182. Aramburu A., Alvarado‐Gamarra G., Cornejo R., et al., “Ultra‐processed Foods Consumption and Health‐related Outcomes: A Systematic Review of Randomized Controlled Trials,” Frontiers in Nutrition 11 (2024): 1421728, 10.3389/fnut.2024.1421728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 183. Jörg S., Kissel J., Manzel A., et al., “High Salt Drives Th17 Responses in Experimental Autoimmune Encephalomyelitis Without Impacting Myeloid Dendritic Cells,” Experimental Neurology 279 (2016): 212–222. [DOI] [PubMed] [Google Scholar]
  • 184. Balan Y., Packirisamy R. M., and Mohanraj P. S., “High Dietary Salt Intake Activates Inflammatory Cascades via Th17 Immune Cells: Impact on Health and Diseases,” Archives of Medical Science: AMS 18, no. 2 (2022): 459–465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 185. Temple N. J., “A Fresh Look at Problem Areas in Research Methodology in Nutrition,” Nutrients 17, no. 6 (2025): 972, 10.3390/nu17060972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 186. Martínez‐López E., Pérez‐Guerrero E. E., Torres‐Carrillo N. M., López‐Quintero A., Betancourt‐Núñez A., and Gutiérrez‐Hurtado I. A., “Methodological Aspects in Randomized Clinical Trials of Nutritional Interventions,” Nutrients 14, no. 12 (2022): 2365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 187. Mirmiran P., Bahadoran Z., and Gaeini Z., “Common Limitations and Challenges of Dietary Clinical Trials for Translation Into Clinical Practices,” International journal of endocrinology and metabolism 19, no. 3 (2021): 108170, 10.5812/ijem.108170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 188. Elizabeth L., Machado P., Zinöcker M., Baker P., and Lawrence M., “Ultra‐Processed Foods and Health Outcomes: A Narrative Review,” Nutrients 12, no. 7 (2020): 1955, 10.3390/nu12071955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 189. Shu L., Zhang X., Zhu Q., Lv X., and Si C., “Association Between Ultra‐processed Food Consumption and Risk of Breast Cancer: A Systematic Review and Dose‐response Meta‐analysis of Observational Studies,” Frontiers in Nutrition 10 (2023): 1250361, 10.3389/fnut.2023.1250361. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The authors have nothing to report


Articles from Molecular Nutrition & Food Research are provided here courtesy of Wiley

RESOURCES